{"id":2273,"date":"2023-06-25T17:55:01","date_gmt":"2023-06-25T17:55:01","guid":{"rendered":"https:\/\/kidneydiseaseclinic.net\/kdc\/varenicline\/"},"modified":"2023-06-25T18:04:21","modified_gmt":"2023-06-25T18:04:21","slug":"varenicline","status":"publish","type":"post","link":"https:\/\/kidneydiseaseclinic.net\/kdc\/varenicline\/","title":{"rendered":"Varenicline"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/kidneydiseaseclinic.net\/renaldrugs\/img\/Varenicline.JPG\"><\/p>\n<h3>  CLINICAL USE<\/h3>\n<p>Aid to smoking cessation<\/p>\n<h3> DOSE IN NORMAL RENAL FUNCTION<\/h3>\n<p>0.5 mg once daily for 3 days, 0.5 mg twice daily for 3 days, then 0.5\u20131 mg twice daily<\/p>\n<h3>  PHARMACOKINETICS<\/h3>\n<li> Molecular weight &nbsp;  &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; : 361.3 (as tartrate)<\/li>\n<li>  %Protein binding  &nbsp; &nbsp; &nbsp;  &nbsp;  &nbsp;  &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; : &lt;20<\/li>\n<li>  %Excreted unchanged in urine &nbsp; &nbsp; : 92<\/li>\n<li> Volume of distribution (L\/kg) &nbsp; &nbsp; &nbsp; : 415 litres<\/li>\n<li>half-life \u2013 normal\/ESRD (hrs)&nbsp; &nbsp; &nbsp; : 24\/Increased<br \/>\n<h3>  DOSE IN RENAL IMPAIRMENT<\/h3>\n<h4>GFR (mL\/MIN)<\/h4>\n<p>Initial doses as for normal renal function, then maintenance doses of: 30\u201350 1 mg once or twice daily 10\u201330 1 mg once daily<\/li>\n<li> &lt;10 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; : 0.5\u20131 mg once daily<br \/>\n<h3> DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES<\/h3>\n<\/li>\n<li> CAPD  &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;: Unknown dialysability. Dose as in GFR &lt;10 mL\/min<\/li>\n<li> HD &nbsp;  &nbsp; &nbsp;  &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; : Dialysed. Dose as in GFR &lt;10 mL\/min<\/li>\n<li>HDF\/high flux  &nbsp; : Dialysed. Dose as in GFR &lt;10 mL\/min<\/li>\n<li>CAV\/VVHD  &nbsp; &nbsp; &nbsp;: Dialysed. Dose as in GFR=10\u201330 mL\/min<br \/>\n<h3> IMPORTANT DRUG INTERACTIONS<\/h3>\n<p>Potentially hazardous interactions with other drugs<\/li>\n<li>None known<br \/>\n<h3> ADMINISTRATION<\/h3>\n<h4> Reconstition<\/h4>\n<p>\u2013<\/p>\n<h4>  Route<\/h4>\n<p>Oral<\/p>\n<h4>  Rate of Administration<\/h4>\n<p>\u2013<\/p>\n<h4>Comments<\/h4>\n<p>\u2013 .<\/li>\n","protected":false},"excerpt":{"rendered":"<p>CLINICAL USE Aid to smoking cessation DOSE IN NORMAL RENAL<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[7],"class_list":["post-2273","post","type-post","status-publish","format-standard","hentry","category-blog","tag-post-by-auto-php"],"_links":{"self":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts\/2273","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/comments?post=2273"}],"version-history":[{"count":1,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts\/2273\/revisions"}],"predecessor-version":[{"id":2323,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts\/2273\/revisions\/2323"}],"wp:attachment":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/media?parent=2273"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/categories?post=2273"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/tags?post=2273"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}